BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 26690922)

  • 1. Methylation of C9orf72 expansion reduces RNA foci formation and dipeptide-repeat proteins expression in cells.
    Bauer PO
    Neurosci Lett; 2016 Jan; 612():204-209. PubMed ID: 26690922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antisense transcripts of the expanded C9ORF72 hexanucleotide repeat form nuclear RNA foci and undergo repeat-associated non-ATG translation in c9FTD/ALS.
    Gendron TF; Bieniek KF; Zhang YJ; Jansen-West K; Ash PE; Caulfield T; Daughrity L; Dunmore JH; Castanedes-Casey M; Chew J; Cosio DM; van Blitterswijk M; Lee WC; Rademakers R; Boylan KB; Dickson DW; Petrucelli L
    Acta Neuropathol; 2013 Dec; 126(6):829-44. PubMed ID: 24129584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of DNA hypermethylation in the cerebellum of c9FTD/ALS patients.
    Belzil VV; Bauer PO; Gendron TF; Murray ME; Dickson D; Petrucelli L
    Brain Res; 2014 Oct; 1584():15-21. PubMed ID: 24530272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced C9orf72 gene expression in c9FTD/ALS is caused by histone trimethylation, an epigenetic event detectable in blood.
    Belzil VV; Bauer PO; Prudencio M; Gendron TF; Stetler CT; Yan IK; Pregent L; Daughrity L; Baker MC; Rademakers R; Boylan K; Patel TC; Dickson DW; Petrucelli L
    Acta Neuropathol; 2013 Dec; 126(6):895-905. PubMed ID: 24166615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenic determinants and mechanisms of ALS/FTD linked to hexanucleotide repeat expansions in the C9orf72 gene.
    Wen X; Westergard T; Pasinelli P; Trotti D
    Neurosci Lett; 2017 Jan; 636():16-26. PubMed ID: 27619540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular Mechanisms of Neurodegeneration Related to
    Babić Leko M; Župunski V; Kirincich J; Smilović D; Hortobágyi T; Hof PR; Šimić G
    Behav Neurol; 2019; 2019():2909168. PubMed ID: 30774737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C9orf72 hypermethylation protects against repeat expansion-associated pathology in ALS/FTD.
    Liu EY; Russ J; Wu K; Neal D; Suh E; McNally AG; Irwin DJ; Van Deerlin VM; Lee EB
    Acta Neuropathol; 2014 Oct; 128(4):525-41. PubMed ID: 24806409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. There has been an awakening: Emerging mechanisms of C9orf72 mutations in FTD/ALS.
    Gitler AD; Tsuiji H
    Brain Res; 2016 Sep; 1647():19-29. PubMed ID: 27059391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the dipeptide repeat protein in the molecular pathogenesis of c9FTD/ALS.
    Yamakawa M; Ito D; Honda T; Kubo K; Noda M; Nakajima K; Suzuki N
    Hum Mol Genet; 2015 Mar; 24(6):1630-45. PubMed ID: 25398948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insights into the pathogenic mechanisms of Chromosome 9 open reading frame 72 (C9orf72) repeat expansions.
    Todd TW; Petrucelli L
    J Neurochem; 2016 Aug; 138 Suppl 1():145-62. PubMed ID: 27016280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequestration of multiple RNA recognition motif-containing proteins by C9orf72 repeat expansions.
    Cooper-Knock J; Walsh MJ; Higginbottom A; Robin Highley J; Dickman MJ; Edbauer D; Ince PG; Wharton SB; Wilson SA; Kirby J; Hautbergue GM; Shaw PJ
    Brain; 2014 Jul; 137(Pt 7):2040-51. PubMed ID: 24866055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinical and pathological phenotype of C9ORF72 hexanucleotide repeat expansions.
    Simón-Sánchez J; Dopper EG; Cohn-Hokke PE; Hukema RK; Nicolaou N; Seelaar H; de Graaf JR; de Koning I; van Schoor NM; Deeg DJ; Smits M; Raaphorst J; van den Berg LH; Schelhaas HJ; De Die-Smulders CE; Majoor-Krakauer D; Rozemuller AJ; Willemsen R; Pijnenburg YA; Heutink P; van Swieten JC
    Brain; 2012 Mar; 135(Pt 3):723-35. PubMed ID: 22300876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS.
    DeJesus-Hernandez M; Mackenzie IR; Boeve BF; Boxer AL; Baker M; Rutherford NJ; Nicholson AM; Finch NA; Flynn H; Adamson J; Kouri N; Wojtas A; Sengdy P; Hsiung GY; Karydas A; Seeley WW; Josephs KA; Coppola G; Geschwind DH; Wszolek ZK; Feldman H; Knopman DS; Petersen RC; Miller BL; Dickson DW; Boylan KB; Graff-Radford NR; Rademakers R
    Neuron; 2011 Oct; 72(2):245-56. PubMed ID: 21944778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unconventional features of C9ORF72 expanded repeat in amyotrophic lateral sclerosis and frontotemporal lobar degeneration.
    Vatovec S; Kovanda A; Rogelj B
    Neurobiol Aging; 2014 Oct; 35(10):2421.e1-2421.e12. PubMed ID: 24836899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retention of hexanucleotide repeat-containing intron in C9orf72 mRNA: implications for the pathogenesis of ALS/FTD.
    Niblock M; Smith BN; Lee YB; Sardone V; Topp S; Troakes C; Al-Sarraj S; Leblond CS; Dion PA; Rouleau GA; Shaw CE; Gallo JM
    Acta Neuropathol Commun; 2016 Feb; 4():18. PubMed ID: 26916632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The C9orf72 repeat size correlates with onset age of disease, DNA methylation and transcriptional downregulation of the promoter.
    Gijselinck I; Van Mossevelde S; van der Zee J; Sieben A; Engelborghs S; De Bleecker J; Ivanoiu A; Deryck O; Edbauer D; Zhang M; Heeman B; Bäumer V; Van den Broeck M; Mattheijssens M; Peeters K; Rogaeva E; De Jonghe P; Cras P; Martin JJ; de Deyn PP; Cruts M; Van Broeckhoven C
    Mol Psychiatry; 2016 Aug; 21(8):1112-24. PubMed ID: 26481318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Japanese amyotrophic lateral sclerosis patients with GGGGCC hexanucleotide repeat expansion in C9ORF72.
    Konno T; Shiga A; Tsujino A; Sugai A; Kato T; Kanai K; Yokoseki A; Eguchi H; Kuwabara S; Nishizawa M; Takahashi H; Onodera O
    J Neurol Neurosurg Psychiatry; 2013 Apr; 84(4):398-401. PubMed ID: 23012445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mouse Models of
    Batra R; Lee CW
    Front Cell Neurosci; 2017; 11():196. PubMed ID: 28729824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C9orf72 isoforms in Amyotrophic Lateral Sclerosis and Frontotemporal Lobar Degeneration.
    Xiao S; MacNair L; McLean J; McGoldrick P; McKeever P; Soleimani S; Keith J; Zinman L; Rogaeva E; Robertson J
    Brain Res; 2016 Sep; 1647():43-49. PubMed ID: 27134035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RNA-mediated toxicity in C9orf72 ALS and FTD.
    McEachin ZT; Parameswaran J; Raj N; Bassell GJ; Jiang J
    Neurobiol Dis; 2020 Nov; 145():105055. PubMed ID: 32829028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.